Preliminary Agenda Speakers

7:00 am -

Download the preliminary agenda for a sneak peek of what we’ll be sharing next February. Full agenda will be released in December 2026.

Speakers:

Aaron Goldman
Director - Faculty & Instructor in Medicine
Harvard Medical School
Aaron Liao
Principal Scientist - Research
Abbvie
Amey Bandekar
Associate Director - Drug Product Development
Sanofi
Anastasiya Manuilov
Associate Director
ModeX Therapeutics
Ankit Kanth
Senior Scientist
Bristol Myers Squibb
Anni Chang
Scientific Liaison & Senior Scientist
U.S. Pharmacopeia
Cangjie Yang
Associate Director
Zipcode Bio
Dan Shores
Partner
Rothwell Figg
Gilles Divita
CEO
Aanastra Inc
Harry An
Director Process Development
Editas Medicine
Harsh Chauhan
Senior Director, Formulation & External Manufacturing
Alltrna
Hongjing Xia
Principal Scientist II
Novartis AG
Hongming Chen
Co-Founder, Chief Research & Development Officer
METiS Therapeutics
Jamie Tsung
Director
Alnylam Pharmaceuticals
Kenneth Lyon
Senior Principal Scientist
GlaxoSmithKline
Kevin Tan
Scientist, LNP Discovery
Strand Therapeutics Inc.
Liping Zhou
Senior Director
AstraZeneca
Mansoor Amiji
Distinguished Professor
Northeastern University
Mark Hayes
Vice President - Research
Akagera Medicines
Rasangi Wimalasinghe
Principal Scientist
Sanofi
Ruchi Shah
Director
GlaxoSmithKline
Roger Adami
Chief Technology Officer
Land Tx
Stephanie Knapp
Senior Director, LNP Process Development
Nava Therapeutics
Umberto Capasso Palmiero
Senior Scientist
Novo Nordisk
Wendy Walton
Director
Eli Lilly & Co.
Yi Pu
Head of Drug Product Analytical Development
Prime Medicine
Zichuan (Zack) Zhang
Senior Director, Analytical Research & Development
Beam Therapeutics Inc.